Skip to main content
All Comparisons

Platform Comparison

Solidus vs DealForma: Which Biopharma Deal Platform Fits Your Workflow?

DealForma has been a go-to for biopharma licensing comps since 2013. Solidus takes the deal intelligence layer further with 1,600+ verified transactions, 21 integrated analytical engines, and real-time benchmarking starting at $199/month.

Two Different Approaches to Deal Intelligence

DealForma built its reputation as a curated licensing deal database. It excels at providing searchable deal comps with clean upfront, milestone, and royalty data points that BD professionals have relied on for term sheet benchmarking.

Solidus was built by practitioners who needed more than a reference database. It integrates deal comps with valuation engines, partner matching, competitive dynamics modeling, and AI-powered analysis — so your team goes from “what did comparable deals pay?” to “what should this deal be worth, and who should we talk to?” in one platform.

Feature Comparison

FeatureSolidusDealForma
Licensing Deal Comps Database
Upfront/Milestone Benchmarking
rNPV Valuation Engine
Monte Carlo Simulation (10K iterations)
AI Deal Memos & Narratives
Partner Matching (850+ companies)
Competitive Dynamics Engine
Real Options Valuation
Pharma Intent Scoring
Deal Waterfall Analysis
Royalty Rate Benchmarking
Therapeutic Area Filtering
PDF/Excel Export
Free Tier Available
Self-Serve Signup (No Sales Call)
API Access

Key Differentiators

From Comps to Conclusions

DealForma gives you the data points. Solidus gives you the analysis. Run rNPV models, Monte Carlo simulations, and scenario comparisons directly on top of deal benchmarks — no spreadsheet gymnastics required.

21 Integrated Analytical Engines

Deal waterfall, tornado sensitivity, competitive dynamics, real options valuation, partner matching, Pharma Intent Scoring, AI deal memos — all connected to the same deal dataset. DealForma provides the database; Solidus provides the analytical layer.

Built by Deal Practitioners

Solidus was built by an M&A advisory team that structures real transactions. The engines reflect how BD professionals actually work — not how a data vendor thinks they should. Every feature maps to a real workflow in deal evaluation.

Accessible Pricing, No Procurement

Start free, upgrade to Pro at $199/month (annual) with no contract. DealForma requires annual subscriptions typically starting at $15K-$30K+. Solidus makes institutional-grade deal intelligence accessible to emerging biotech teams, not just large pharma.

Which Platform Fits Your Team?

Choose Solidus if you need to:

  • Model deal economics with rNPV, Monte Carlo, and scenario analysis
  • Generate AI-powered deal memos and negotiation playbooks
  • Match assets to potential partners with intent scoring
  • Track competitive dynamics across therapeutic areas in real time
  • Get started quickly without a procurement cycle or six-figure budget
  • Work across the full deal lifecycle, not just the comp search

Choose DealForma if you need to:

  • Search a well-established licensing deal comps database
  • Reference historical deal terms for term sheet benchmarking
  • Access deal summaries and press release aggregation
  • Work within a team already trained on DealForma's interface

Pricing Comparison

Both platforms serve biopharma BD teams. The difference is access model and analytical depth.

Solidus Pro

$199/month (annual)

or $299/month month-to-month

  • All 21 analytical engines
  • Unlimited benchmarks & exports
  • AI deal memos & negotiation playbooks
  • Partner matching & intent scoring
  • Free tier available — no contract required

DealForma

~$15K-$30K+/year

Annual subscriptions, module-dependent

  • Deal comps database access
  • Annual commitment typically required
  • No integrated valuation engines
  • No free tier

Frequently Asked Questions

Is Solidus a good alternative to DealForma for biopharma deal comps?

Yes. DealForma is well-established for licensing deal comparables, particularly upfront and milestone data. Solidus goes further by integrating deal comps with 21 analytical engines — rNPV modeling, Monte Carlo simulation, competitive dynamics, partner matching, and AI-generated deal memos — so you move from data to decision in one workflow. If your team needs more than a reference database, Solidus is built for that.

How does Solidus pricing compare to DealForma?

DealForma subscriptions typically run $15,000-$30,000+ per year depending on modules and seat count, with annual contracts. Solidus Pro starts at $199/month (annual) or $299/month with no contract required. Both platforms offer tiered access, but Solidus provides transparent self-serve pricing with a free tier that includes core benchmarking across 12 therapeutic areas.

Can I use Solidus and DealForma together?

Absolutely. Some BD teams use DealForma as a reference database for historical deal comps and Solidus for active deal modeling — running rNPV scenarios, Monte Carlo simulations, and partner matching against their specific asset parameters. The platforms are complementary: DealForma for looking up precedent, Solidus for building the analytical case around a live transaction.

Explore Solidus

More Than a Deal Database

Run your asset through Solidus's 21 engines and see the deal intelligence that a reference database alone can't provide.